首页> 外文期刊>Science of advanced materials >Preparation of Snake Neurotoxin Nanocapsules and the Analgesic Mechanism of P38 Mitogen-Activated Protein Kinase Signal Pathway Combining Snake Neurotoxin Nanocapsules with Gabapentin
【24h】

Preparation of Snake Neurotoxin Nanocapsules and the Analgesic Mechanism of P38 Mitogen-Activated Protein Kinase Signal Pathway Combining Snake Neurotoxin Nanocapsules with Gabapentin

机译:蛇神经毒素纳米膜的制备及P38丝裂型蛋白激酶信号途径与加巴亨坦植物组合蛇神经毒素纳米胶囊的镇痛机理

获取原文
获取原文并翻译 | 示例
           

摘要

This study aimed to explore the analgesic effect of snake neurotoxin combined with gabapentin (Gab) on neuropathic pain in rats with chronic compression injury (CCI) of the sciatic nerve based on the nanotechnology. Firstly, various solutions were prepared to obtain the inner water phase, the oil phase, the outer water phase, and the dilution phase. Poly(lactic-co-glycolic) Acid (PLGA) and polyethylene glycol-poly(lactic-co-glycolic) acid (PEG-PLGA) were added to the prepared oil phase solution to obtain the PLGA snake neurotoxin nanocapsule and PEG-PLGA snake neurotoxin nanocapsule, respectively. After the nanocapsules were obtained, a rat CCI model was further modelled, and the reactive oxygen species (ROS) content in the rat brain tissue was analyzed and tested by the kit, and the optimal physical conditions for preparing the nanocapsules were tested. In order to test the effect of nanocapsules on the p38 mitogen-activated protein kinase (MAPK) signaling pathway, the rats were divided into Control group, Sham group, CCI group, Gabapentin (Gab) group, and PEG-PLGA snake neurotoxin nanocapsule+ Gab group. The rats in different groups were given abdominal injections to compare relevant indicators of signal pathway. In the experiment, neuropathic pain was related to changes in ROS content, and snake neurotoxin nanocapsules could reduce the ROS content; PLGA snake neurotoxin nanocapsules and PEG-PLGA snake neurotoxin nanocapsules had encapsulation efficiencys of 24.7% and 22.8% and drug loading of 3.28% and 3.02%, respectively, and the particle sizes of prepared nanocapsules were 760 nm similar to 1,150 nm. Besides, the phase transition temperature of about 50 degrees C and the light time of 1 h can accelerate the release of nanocapsules to the greatest extent; and the snake neurotoxin could inhibit the activation of p38 MAPK signaling pathway so as to play the analgesic effects on neuropathic pain.
机译:本研究旨在探讨蛇神经毒素与甘地蛋白(GAB)对基于纳米技术坐骨神经慢性压缩损伤(CCI)大鼠神经性疼痛的镇痛作用。首先,制备各种溶液以获得内水相,油相,外水相和稀释相。将聚(乳酸 - 共乙醇酸)酸(PLGA)和聚乙二醇 - 聚(乳酸二乙醇酸)酸(PEG-PLGA)加入到制备的油相溶液中,得到PLGA蛇神经毒素纳米胶囊和PEG-PLGA蛇神经毒素纳米腐植物。获得纳米胶囊后,进一步建模大鼠CCI模型,并通过试剂盒分析并测试大鼠脑组织中的反应性氧物质(ROS)含量,并测试用于制备纳米胶囊的最佳物理条件。为了测试纳米胶囊对P38丝裂剂活化的蛋白激酶(MAPK)信号传导途径的影响,将大鼠分为对照组,假手术组,CCI组,加巴亨顿素(GAB)组,PEG-PLGA蛇神经毒素纳米胶囊+ GAB团体。不同组中的大鼠被给予腹部注射以比较信号途径的相关指标。在实验中,神经性疼痛与ROS含量的变化有关,蛇神经毒素纳米胶囊可以降低ROS含量; PLGA蛇神经毒素纳米胶囊和PEG-PLGA蛇神经毒素纳米胶囊的封装效率分别为24.7%和22.8%,分别为3.28%和3.02%的药物负载,并且制备的纳米胶囊的粒度为760nm,类似于1,150nm。此外,约50℃的相转变温度和1小时的光时间可以在最大程度上加速纳米胶囊的释放;蛇神经毒素可以抑制P38 MAPK信号通路的激活,以便对神经性疼痛发挥镇痛作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号